Skip to main content
. 2017 Aug 22;8(42):73087–73097. doi: 10.18632/oncotarget.20391

Table 2. Results of the meta-analysis.

Author (year, journal) Incidence rate per 1000 (95% CI) IRR Crude HR Adjusted HR
In cases In controls Ratio (95% CI) p-value Ratio (95% CI) p-value Ratio (95% CI) p-value
Dementia including Alzheimer
 Kao, et al. (2016) 2.36 (1.22–4.55) 1.86 (0.79–4.39) 1.27 (0.43–3.74) 0.90 (0.62–1.31) 1.21 (0.82–1.79)
 Chung, et al. (2016) 3.44 (2.00–5.90) 1.69 (0.69–4.14) 2.02 (0.71–5.73) 2.05 (0.64–6.52) 1.76 (0.55–5.59)
 Nead, et al. (2016) - - - - 1.66 (1.06–2.61)
 Nead, et al. (2016)a 2.90 (1.56–5.36) 1.90 (1.31–2.76) 1.53 (0.74–3.14) - 2.04 (1.23–3.40)
 Nead, et al. (2017) 7.89 (5.97–10.44) 3.50 (2.84–4.31) 2.26 (1.69–3.20) 3.00 (2.33–3.87) 2.21 (1.71–2.85)
 Khosrow-Khaver, et al. (2017) 7.40 (6.55–8.35) 4.40 (3.76–5.15) 1.68 (1.38–2.05) - 1.02 (0.87–1.19)
 Jhan, et al. (2017) - - - 1.96 (1.55–2.48) 1.84 (1.32–2.57)
 Overall by random effect model 4.67 (3.10–7.04) 2.81 (1.96–4.03) 1.78 (1.51–2.10) < 0.001 1.80 (1.05–3.10) 0.032 1.59 (1.16–2.18) 0.004
Heterogeneity, I2 (%) 84.9% (66.3–93.2%) 82.3% (59.2–92.3%) 0.0% (0.0–69.3%) 0.606 89.1% (74.7–95.3%) < 0.001 82.2% (64.5–91.1%) < 0.001
Alzheimer disease only
 Chung, et al. (2016) 3.44 (2.00–5.90) 1.69 (0.69–4.14) 2.03 (0.71–5.77) 2.05 (0.64–6.52) 1.76 (0.55–5.59)
 Nead, et al. (2016) - - - - 1.66 (1.06–2.61)
 Nead, et al. (2016) 2.90 (1.56–5.36) 1.90 (1.31–2.76) 1.53 (0.74–3.14) - 2.04 (1.23–3.40)
 Jhan, et al. (2017) - - - 1.96 (1.55–2.48) 1.84 (1.32–2.57)
 Overall by random effect model 3.19 (2.13–4.79) 1.87 (1.32–2.64) 1.67 (0.92–3.03) 0.09 1.96 (1.56–2.47) < 0.001 1.83 (1.45–2.30) < 0.001
Heterogeneity, I2 (%) 0.0% (NA) 0.0% (NA) 0.0% (NA) 0.656 0.0% (NA) 0.941 0.0% (0.0–0.0%) 0.949

NA, not available; IRR, incidence rate ratio; HR, hazard ratio; CI, confidence interval.

a, publicated on Scientific Reports.

HHS Vulnerability Disclosure